Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity

Toxicology Letters

Volumn 167, Issue 2, 2006, Pages 95-105

  Takayanagi, Sayaka ^a   Tokunaga, Takatoshi ^a   Liu, Xiaohui ^a   Okada, Hiroyuki ^a   Matsushima, Ayami ^a   Shimohigashi, Yasuyuki ^a  

^a Interdisciplinary Graduate School of Engineering Science   (Japan)

Author keywords

Bisphenol A; Endocrine disruptor; Estrogen related receptor ; Low dose effects; Nuclear receptors; Receptor binding

Indexed keywords

4 HYDROXYTAMOXIFEN; 4 NONYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN RELATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; RECEPTOR BINDING; REPORTER GENE;

BINDING, COMPETITIVE; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR ALPHA; GENES, REPORTER; HELA CELLS; HUMANS; LIGANDS; PHENOLS; RADIOLIGAND ASSAY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; TAMOXIFEN;

MAMMALIA;

EID: 33751005817     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.08.012     Document Type: Article

References (40)

1. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., and Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 114 (2006) 106-112
2. Ashby J., Tinwell H., and Haseman J. Lack of effects for low dose levels of bisphenol A and diethystilbestrol on the prostate gland of CF1 mice exposed in utero. Reg. Toxicol. Pharmacol. 30 (1999) 156-166
3. Cagen S.Z., Waechter J.M., Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., Joiner R.L., Shiotsuka R.N., Veenstra G.E., and Harris L.R. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol. Sci. 50 (1999) 36-44
4. Coward P., Lee D., Hull M.V., and Lehmann J.M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8880-8884
5. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., and Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12 (1998) 3343-3356
6. De Lean A., Munson P.J., and Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235 (1978) E97-E102
7. Dodds E.C., and Lawson W. Moleclar structure in relation to oestrogenic activity. Compounds without a phenanthrene nucleus. Proc. Royal Soc. London B 125 (1938) 222-232
8. Eudy J.D., Yao S., Weston M.D., Ma-Edmonds M., Talmadge C.B., Cheng J.J., Kimberling W.J., and Sumegi J. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics 50 (1998) 382-384
9. Fang H., Tong W., Shi L.M., Blair R., Perkins R., Branham W., Hass B.S., Xie Q., Dial S.L., Moland C.L., and Sheehan D.M. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 14 (2001) 280-294
10. Giguère V. To ERR in the estrogen pathway Trends Endocrinol. Metabolism 13 (2002) 220-225
11. Gray G.M., Cohen J.T., Cunha G., Hughes C., McConnell E.E., Rhomberg L., Sipes I.G., and Mattison D. Weight of the evidence evaluation of low dose reproductive and developmental effects of bisphenol A. Human Ecol. Risk Assess. 10 (2004) 875-921
12. Greschik H., Wurtz J.-M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., and Renaud J.-P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 (2002) 303-313
13. Greschik H., Flaig R., Renaud J.-P., and Moras D. Structural basis for the deactivation of the estrogen-related receptor γ by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J. Biol. Chem. 279 (2004) 33639-33646
14. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc. Soc. Exp. Biol. Med. 224 (2000) 61-68
15. Heard D.J., Norby P.L., Holloway J., and Vissing H. Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: Tissue-specific isoforms are expressed during development and in the adult. Mol. Endocrinol. 14 (2000) 382-392
16. Hong H., Yang L., and Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274 (1999) 22618-22626
17. Horard B., and Vanacker J.-M. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J. Mol. Endocrinol. 31 (2003) 349-357
18. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., and vom Saal F.S. Exposure to bisphenol A advances puberty. Nature 401 (1999) 763-764
19. Huppunen J., and Aarnisalo P. Dimerization modulates the activity of the orphan nuclear receptor ERRγ. Biochem. Biophys. Res. Commun. 314 (2004) 964-970
20. Kaiser J. Panel cautiously confirms low dose effects. Science 290 (2000) 695-697
21. Kawai K., Nozaki T., Nishikata H., Aou S., Takii M., and Kubo C. Aggressive behavior and serum testosterone concentration during the maturation process of male mice: the effects of fetal exposure to bisphenol A. Environ. Health Perspect. 111 (2003) 175-178
22. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., and Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 (1993) 2279-2286
23. Kubo K., Arai O., Omura M., Watanabe R., Ogata R., and Aou S. Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci. Res. 45 (2003) 345-356
24. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139 (1998) 4252-4263
25. Lorke D.E., Süsens U., Borgmeyer U., and Hermans-Borgmeyer I. Differential expression of the estrogen receptor-related receptor γ in the mouse brain. Mol. Brain Res. 77 (2000) 277-280
26. Markey C.M., Luque E.H., Munoz de Toro M., Sonnenschein C., and Soto A.M. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod. 65 (2001) 1215-1223
27. Nakai M., Tabira Y., Asai D., Yakabe Y., Shinmyozu T., Noguchi M., Takatsuki M., and Shimohigashi Y. Binding characteristics of dialkyl phthalates for the estrogen receptor. Biochem. Biophys. Res. Commun. 254 (1999) 311-314
28. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., and Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 105 (1997) 70-76
29. National Toxicology Program (NTP), 2001. U.S. Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health. National Toxicology Program's Report of the Endocrine Disrutors Low Dose Peer Review. Available on the NTP web site: http://ntp-server.niehs.nih.gov/htdocs/liason/LowDoseWebPage.html
30. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 97 (1999) 161-163
31. Olea N., Pulgar R., Pérez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A.M., and Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 104 (1996) 298-305
32. Palanza P., Howdeshell K.L., Parmigiani S., and vom Saal F.S. Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ. Health Perspect. 110 Suppl. 3 (2002) 415-422
33. Robinson-Rechavi M., Carpentier A.-S., Duffraisse M., and Laudet V. How many nuclear hormone receptors are there in the human genome?. Trends Genet. 17 (2001) 554-556
34. Safe S.H., Pallaroni L., Yoon K., Gaido K., Ross S., and McDonnell D. Problems for risk assessment of endocrine-active estrogenic compounds. Environ. Health Perspect. 110 Suppl 6 (2002) 925-929
35. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 (1998) 327-339
36. Tremblay G.B., Kunath T., Bergeron D., Lapointe L., Champigny C., Bader J.A., Rossant J., and Giguère V. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERRβ. Genes Dev. 15 (2001) 833-838
37. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., Nagel S.C., Parmigiani S., and Welshons W.V. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health 14 (1998) 239-260
38. vom Saal F.S., and Hughes C. An extensive new literature concerning low dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 113 (2005) 926-933
39. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., and vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 111 (2003) 994-1006
40. Xu L.-C., Sun H., Chen J.-F., Bian Q., Qian J., Song L., and Wang X.-R. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. Toxicology 216 (2005) 197-203